April 22, 2021
UNC Lineberger's Chad Pecot, MD — a cancer survivor himself — launched EnFuego Therapeutics with the help of UNC KickStart Venture Services to develop RNA-interference drugs that silence cancer-related gene mutations.
September 25, 2020
New research by Chad Pecot, MD, and colleagues shows the potential for targeting a specific circular RNA, known as CDR1as, to attack lung squamous cell cancer.
April 17, 2019
A study by University of North Carolina Lineberger Comprehensive Cancer Center researchers helps explain how tumors recruit blood vessels that provide fuel for their growth as well as an avenue for the tumors to spread. In the journal Oncogene, the researchers also reported they built on these findings to uncover a potential treatment strategy to …
February 11, 2019
UNC Lineberger awarded grants to 14 scientists and research teams in the fall grant awards cycle. Applications for the next round of funding will be due March 15.
